Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Regulatory Filings 2014

Apr 28, 2014

29831_rns_2014-04-28_beceb7b2-b220-4eaf-b84d-4f07254ad4fe.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 pf8k424v.htm PFIZER INC. 8-K Pfizer Inc. 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 24, 2014

PFIZER INC. (Exact name of registrant as specified in its charter)

Delaware 1-3619 13-5315170
(State or other Jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
235 East 42nd Street New York, New York (Address of principal executive offices) 10017 (Zip Code)

Registrant's telephone number, including area code:

(212) 733-2323 Not Applicable (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07
(a) Pfizer’s Annual Meeting of Shareholders was held on April 24, 2014.
(b) Shareholders voted on the matters set forth below.

1. The nominees for election to the Board of Directors were elected, each for a one-year term, based upon the following votes:

Nominee Votes For Votes Against Abstentions Broker non-votes
Dennis A. Ausiello 4,429,512,835 42,224,116 16,411,177 869,037,171
W. Don Cornwell 4,249,141,223 222,240,877 16,776,345 869,037,171
Frances D. Fergusson 4,415,014,133 57,256,348 15,890,675 869,037,171
Helen H. Hobbs 4,435,017,252 37,850,299 15,295,402 869,037,171
Constance J. Horner 4,377,963,784 94,141,776 16,054,899 869,037,171
James M. Kilts 4,380,011,462 88,098,189 20,054,201 869,037,171
George A. Lorch 4,420,010,648 51,225,218 16,926,258 869,037,171
Shantanu Narayen 4,429,305,816 41,670,510 17,184,262 869,037,171
Suzanne Nora Johnson 4,400,824,085 67,960,352 19,370,519 869,037,171
Ian C. Read 4,321,012,579 129,821,886 37,324,299 869,037,171
Stephen W. Sanger 4,400,496,417 65,959,599 21,704,215 869,037,171
Marc Tessier-Lavigne 4,434,264,521 33,986,253 19,908,404 869,037,171

2. The proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2014 was approved based upon the following votes:

Votes for approval 5,265,709,410 71,855,336 19,635,794 N/A
Votes against
Abstentions
Broker non-votes
3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes :
Votes for approval 4,242,933,314
Votes against 195,788,864
Abstentions 49,430,064
Broker non-votes 869,037,171

4. The proposal to approve the Pfizer Inc. 2014 Stock Plan was approved based upon the following votes:

Votes for approval 3,931,323,904
Votes against 527,114,639
Abstentions (Have the same effect as a vote against this proposal under New York Stock Exchange rules) 29,724,403
Broker non-votes 869,037,171
5. The shareholder proposal regarding the approval of political contributions policy was not approved based upon the following votes:
Votes for approval 157,446,437
Votes against 4,149,806,529
Abstentions 180,877,128
Broker non-votes 869,037,171
6. The shareholder proposal regarding lobbying activities was not approved based upon the following votes:
Votes for approval 267,720,617
Votes against 4,027,091,452
Abstentions 193,329,820
Broker non-votes 869,037,171
7. The shareholder proposal regarding action by written consent was not approved based upon the following votes:
Votes for approval 1,955,718,015
Votes against 2,483,420,652
Abstentions 48,999,028
Broker non-votes 869,037,171
(c) Not applicable
(d) Not applicable

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

PFIZER INC.
Dated: April 28, 2014 By: /s/ Atiba D. Adams Atiba D. Adams
Title: Vice President & Corporate Secretary